Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2026-06-25 @ 1:03 AM
Study NCT ID:
NCT07042802
Status:
RECRUITING
Last Update Posted:
2025-12-02
First Post:
2025-06-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer
Sponsor:
Nanjing Leads Biolabs Co.,Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LBL-024-CN006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None